This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: East China University of Science and Technology. Active years: 2020.
Company Filing History:
Years Active: 2020
Title: Hanwen Wei: Innovator in Antibacterial Drug Development
Introduction
Hanwen Wei is a notable inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of antibacterial drugs. His innovative work has led to the creation of compounds that have the potential to combat bacterial infections effectively.
Latest Patents
Hanwen Wei holds 1 patent for his invention titled "Benzoheterocyclic alkylamine compounds and use thereof." This patent discloses benzoheterocyclic alkylamine compounds, or pharmaceutically acceptable salts thereof, and stereoisomers. The preparation method and the use of these compounds in the manufacture of an antibacterial drug as an inhibitor of staphyloxanthin synthesis are also detailed in the patent.
Career Highlights
Throughout his career, Hanwen Wei has worked with prestigious institutions such as East China University of Science and Technology and the Chinese Academy of Sciences. His research has focused on developing innovative solutions to pressing health challenges, particularly in the area of antibacterial treatments.
Collaborations
Hanwen Wei has collaborated with esteemed colleagues, including Yifu Liu and Jian Li. Their combined expertise has contributed to advancing research in the field of pharmaceuticals.
Conclusion
Hanwen Wei's contributions to antibacterial drug development highlight his role as an influential inventor in the pharmaceutical industry. His innovative compounds and research efforts continue to pave the way for new treatments against bacterial infections.